CIDOFOVIR DIHYDRATE (Heritage Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the CIDOFOVIR DIHYDRATE drug offered from Heritage Pharmaceuticals Inc.. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Heritage Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | CIDOFOVIR DIHYDRATE |
SUBSTANCE NAME: | CIDOFOVIR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-08-06 |
END MARKETING DATE: | 0000-00-00 |
CIDOFOVIR DIHYDRATE HUMAN PRESCRIPTION DRUG Details:
Item Description | CIDOFOVIR DIHYDRATE from Heritage Pharmaceuticals Inc. |
LABELER NAME: | Heritage Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 375(mg/5mL) |
START MARKETING DATE: | 2012-08-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 23155-216_620d12cb-e8ab-4a4b-a22e-df505e84c3d0 |
PRODUCT NDC: | 23155-216 |
APPLICATION NUMBER: | ANDA202501 |
Other CIDOFOVIR Pharmaceutical Manufacturers / Labelers: